通过活性局部导向抑制剂对转化后修饰酶进行非全性激活
1Istituto di Cristallografia - Consiglio Nazionale delle Ricerche, Area Science Park, Basovizza, Trieste I-34149, Italy.
Computational and structural biotechnology journal
|December 13, 2023
概括
激活因抑制,一种矛盾的酶行为,发生在活性位子抑制剂在低基质水平下意外激活异位素酶时. 这一发现需要新的药物设计策略,以这些复杂的酶为目标.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 通过抑制激活是一种罕见的生化悖论,其中活性位点抑制剂意外激活酶.
- 这种现象特别适用于诸如酶和蛋白酶之类的外位酶,这些酶在翻译后修改中至关重要.
- 外酸酶具有辅助结合点,使基质相互作用和酶动力学复杂化.
研究的目的:
- 为在外酶中提供非全激活因抑制的理论动力学解释.
- 为了阐明仅通过活性位点抑制来准外酶的复杂性.
- 为了突出低基质水平的抑制剂度的重要性.
主要方法:
- 理论动力学模型被用来解释激活-通过-抑制机制.
- 分析的重点是基于机制的非全性抑制.
- 这项研究检查了不同基质度的抑制剂的剂量反应关系.
主要成果:
- 活性局部结合抑制剂可以导致低基质度的酶激活.
- 这种双重行为表现为一种非单调的双相剂量反应.
- 这项研究为理解这种矛盾激活提供了理论框架.
结论:
- 激活通过抑制可能比以前认为的更为普遍.
- 了解外位素的作用对于有效的药物设计来说至关重要,以这些酶为目标.
- 需要新的策略来解释在酶抑制中的外酸影响.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
08:45Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
6.2K
相关概念视频
Allosteric Regulation
58.0K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.0K
Enzyme Inhibition
78.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.4K
Enzymes
81.6K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.6K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
